Goldman Sachs’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$145M Sell
2,205,758
-165,921
-7% -$10.5M 0.02% 834
2025
Q4
$151M Buy
2,371,679
+736,956
+45% +$45.8M 0.02% 760
2025
Q3
$89.8M Buy
1,634,723
+360,740
+28% +$14.9M 0.01% 1016
2025
Q2
$42.1M Sell
1,273,983
-88,975
-7% -$3.09M 0.01% 1464
2025
Q1
$54.8M Buy
1,362,958
+157,527
+13% +$7.24M 0.01% 1169
2024
Q4
$56.7M Buy
1,205,431
+20,642
+2% +$1.07M 0.01% 1184
2024
Q3
$62.6M Buy
1,184,789
+46,635
+4% +$2.6M 0.01% 1077
2024
Q2
$61.7M Buy
1,138,154
+446,705
+65% +$27M 0.01% 1026
2024
Q1
$48.5M Sell
691,449
-123,995
-15% -$9.59M 0.01% 1188
2023
Q4
$68.1M Buy
815,444
+105,994
+15% +$3.84M 0.01% 979
2023
Q3
$20.9M Sell
709,450
-396,788
-36% -$13.2M 0.01% 1759
2023
Q2
$36.1M Buy
1,106,238
+31,714
+3% +$1.17M 0.01% 1336
2023
Q1
$37.8M Buy
1,074,524
+164,273
+18% +$6.7M 0.01% 1268
2022
Q4
$41.7M Buy
910,251
+232,167
+34% +$9.99M 0.01% 1319
2022
Q3
$32.9M Buy
678,084
+207,331
+44% +$9.98M 0.01% 1433
2022
Q2
$18.5M Sell
470,753
-190,693
-29% -$7.68M 0.01% 1964
2022
Q1
$24.3M Buy
661,446
+102,742
+18% +$3.65M 0.01% 1900
2021
Q4
$25.5M Sell
558,704
-425,761
-43% -$16.4M 0.01% 1910
2021
Q3
$35.2M Buy
984,465
+421,962
+75% +$12.4M 0.01% 1563
2021
Q2
$11.1M Sell
562,503
-242,785
-30% -$5.7M ﹤0.01% 2591
2021
Q1
$18.7M Sell
805,288
-18,476
-2% -$395K 0.01% 1989
2020
Q4
$17.1M Sell
823,764
-75,067
-8% -$1.37M 0.01% 1994
2020
Q3
$19.5M Buy
898,831
+84,192
+10% +$1.97M 0.01% 1755
2020
Q2
$19.2M Buy
814,639
+332,290
+69% +$6.23M 0.01% 1720
2020
Q1
$5.69M Buy
482,349
+155,047
+47% +$1.98M ﹤0.01% 2538
2019
Q4
$3.47M Buy
327,302
+189,598
+138% +$1.95M ﹤0.01% 3237
2019
Q3
$1.57M Buy
137,704
+35,032
+34% +$440K ﹤0.01% 3707
2019
Q2
$1.16M Sell
102,672
-134,157
-57% -$1.29M ﹤0.01% 3899
2019
Q1
$1.92M Buy
236,829
+67,642
+40% +$497K ﹤0.01% 3667
2018
Q4
$1.07M Buy
169,187
+11,028
+7% +$80.9K ﹤0.01% 3921
2018
Q3
$1.56M Sell
158,159
-140,492
-47% -$1.13M ﹤0.01% 3761
2018
Q2
$2.48M Sell
298,651
-55,612
-16% -$463K ﹤0.01% 3493
2018
Q1
$2.55M Sell
354,263
-63,334
-15% -$543K ﹤0.01% 3419
2017
Q4
$3.4M Buy
417,597
+73,031
+21% +$829K ﹤0.01% 3348
2017
Q3
$5M Buy
344,566
+58,548
+20% +$800K ﹤0.01% 3140
2017
Q2
$3.46M Buy
286,018
+234,588
+456% +$3.26M ﹤0.01% 3371
2017
Q1
$661K Sell
51,430
-20,061
-28% -$234K ﹤0.01% 4757
2016
Q4
$869K Sell
71,491
-61,871
-46% -$657K ﹤0.01% 4578
2016
Q3
$1.22M Buy
133,362
+30,523
+30% +$319K ﹤0.01% 4232
2016
Q2
$976K Buy
+102,839
New +$844K ﹤0.01% 4201
2016
Q1
Sell
-35,554
Closed -$372K 7113
2015
Q4
$372K Buy
35,554
+19,420
+120% +$190K ﹤0.01% 5162
2015
Q3
$108K Buy
16,134
+9,099
+129% +$62.1K ﹤0.01% 6434
2015
Q2
$47K Buy
7,035
+2,695
+62% +$17.7K ﹤0.01% 6880
2015
Q1
$29K Sell
4,340
-74,312
-94% -$555K ﹤0.01% 6839
2014
Q4
$630K Buy
78,652
+1,182
+2% +$5.07K ﹤0.01% 5067
2014
Q3
$273K Buy
77,470
+62,473
+417% +$262K ﹤0.01% 5852
2014
Q2
$72K Sell
14,997
-30,830
-67% -$188K ﹤0.01% 6663
2014
Q1
$435K Buy
+45,827
New +$414K ﹤0.01% 5404
2013
Q4
Sell
-10,583
Closed -$80K 6665
2013
Q3
$80K Buy
+10,583
New +$114K ﹤0.01% 6215

Other funds holding CYTK